Andreas Niethammer, a board-certified Oncologist with a PhD in Immunology, is a distinguished Professor of Experimental Oncology. As a seasoned pharmaceutical executive, he brings vast clinical development and research experience to the fields of oncology, immunology, and metabolic disorders. His expertise spans diverse areas, including chemotherapy, immunotherapy, radiotherapy techniques, and pediatric oncology. With a strong track record in clinical oversight, research, and leadership, he actively contributes to advancements in the field.